Researchers at Lund University in Sweden, have in collaboration with colleagues in Copenhagen and Singapore, mapped how the body’s own peptides act to reduce infection and inflammation by deactivating the toxic substances formed in the process.
The study is published in Nature Communications and the researchers believe their discovery could lead to new drugs against infection and inflammation, for example in wound healing.
The toxins that are neutralised, known as lipopolysaccharides (LPS), come from the bacterial cell walls and generate an inflammatory reaction. The reaction is a necessary part of our immune defence system in which our bodies respond quickly and fight invasive bacteria. However, it can be over-activated and become harmful, as observed in infected skin wounds, infections in various organs, or in the case of bacteria spreading to the blood, which can lead to sepsis.
“We know from previous studies what the task of these peptides is but now we have mapped how they proceed in gradually reducing an inflammatory reaction”, says Artur Schmidtchen, professor of dermatology and venereology at Lund University and consultant physician at Skåne University Hospital in Lund.
“By use of advanced biophysics such as nuclear magnetic resonance analysis, combined with molecular modelling and biological studies we show that these peptides form a C-shaped structure which enables the capturing and inactivation of LPS. They also simultaneously interfere with receptor-mediated inflammatory responses”, adds Rathi Saravanan, senior research fellow at Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore, and first author of the study.
“Currently, most drugs aim to more or less completely block a target, such as a receptor. But that risks a deactivation of the immune defence system which can be detrimental and downright dangerous. The body’s own defence mechanisms proceed with greater caution in what is known as a transient manner: the peptides act on their target for a short time to reduce an inflammation towards normalisation. It is the natural functions of these peptides that we want to develop into new drugs”, says Artur Schmidtchen, who has been researching the field of innate immunity for over 20 years.
In addition, the peptides present in thrombin, a common blood protein, are multifunctional and can attack several targets, unlike current drugs.
The dermatology researchers now want to develop a peptide gel for improved wound healing in patient studies.
“That is the primary goal, but we will also be looking at the possibility of developing new drugs against infections in the eyes and various internal organs. This will become a new way of preventing both infection and inflammation without using antibiotics.”
The Latest on: Peptides
via Google News
The Latest on: Peptides
- India- Creative Peptides to Reorganize Chelate Peptides for Scientific Research on April 17, 2019 at 10:10 am
(MENAFN - GetNews) Creative Peptides recently announced to reorganize its chelate peptides, a category added in last September to its already well-established supply list covering a wide variety ... […]
- Global Recombinant Peptides Market 2019 to Witness Growth Based On Rising Incidence of economy Till 2025 on April 17, 2019 at 7:10 am
Apr 17, 2019 (Heraldkeeper via COMTEX) -- The report studies the on global Recombinant Peptides market status and forecast, categorizes the global Recombinant Peptides market size (value & volume) by ... […]
- Finding the right match on April 17, 2019 at 4:30 am
They are similar to proteins – which are also comprised of chains of amino acids – but with shorter chains. Peptides can be used as probes to explore the structure and function of proteins, for ... […]
- Alzheimer’s Disease Toxicity Halted by Synthetic Peptides on April 16, 2019 at 7:00 am
Alzheimer’s disease (AD) is characterized by the formation of large, insoluble deposits, or plaques, of amyloid-β peptide (Aβ) in the brain. These plaques are generated by the aggregation of smaller, ... […]
- Pharm Origins Announces Pepticin Plus, Norwegian Salmon Peptide Based… on April 16, 2019 at 4:00 am
“The clinical trials speak for themselves; Norwegian salmon peptides are able to heal the lining of the gut in a way other types of peptides simply can’t.” -Travis Shoaf, Director of Manufacturing and ... […]
- RNA recognition motifs of disease-linked RNA-binding proteins contribute to amyloid formation on April 16, 2019 at 2:17 am
The full domain of TDP-43 RRM1 and FUS RRM, as well as the β-peptides from these two RRMs, could self-assemble into fibril-like aggregates which are amyloids of parallel β-sheets as verified by X-ray ... […]
- Pharm Origins Announces Pepticin Plus, Norwegian Salmon Peptide Based Digestive Supplement on April 16, 2019 at 2:00 am
Pepticin Plus will feature salmon peptides exclusively from Norway, which are known for their pristine nutritional values. "We have wanted to release a digestive aid for a long time, but we were ... […]
- Enzyme-responsive progelator cyclic peptides for minimally invasive delivery to the heart post-myocardial infarction on April 15, 2019 at 2:30 am
Injectable biopolymer hydrogels have gained attention for use as scaffolds to promote cardiac function and prevent negative left ventricular (LV) remodeling post-myocardial infarction (MI). However, ... […]
- Glycosidase and glycan polymorphism control hydrolytic release of immunogenic flagellin peptides on April 11, 2019 at 12:53 pm
1 Department of Plant Sciences, University of Oxford, Oxford, UK. 2 ZMB Chemical Biology, Faculty of Biology, University of Duisburg-Essen, Essen, Germany. 3 The Graduate School of Environmental and ... […]
via Bing News